Skip to the page

Data / Form D filings / Pneuma Respiratory, Inc.

Pneuma Respiratory, Inc.: Form D filings

Pneuma Respiratory, Inc., a pharmaceuticals company in Boone, NC, filed 21 Form D notices with the SEC between 2018 and 2026. The latest, on July 1, 2026, reports $3.6 million sold of an offering with no set size to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
870 STATE FARM ROAD, SUITE 103-B, Boone, NC, 28607
Phone
(828) 772-2602
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1701794

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 1, 2026New noticeIndefinite$3,570,11519Jun 18, 2026sec.gov
Dec 3, 2025Amendment$3,304,000$3,304,00014Feb 10, 2025sec.gov
Dec 3, 2025Amendment$2,996,000$2,996,00026Nov 29, 2024sec.gov
Jun 23, 2025New notice$3,304,000$3,304,00014Feb 10, 2025sec.gov
May 14, 2025AmendmentIndefinite$2,996,00025Nov 29, 2024sec.gov
May 13, 2025New noticeIndefinite$2,996,00025Dec 31, 2024sec.gov
Dec 23, 2024New noticeIndefinite$7,340,00068Jun 20, 2023sec.gov
Aug 10, 2021Amendment$10,000,050$6,898,219$3,101,83136Jul 15, 2019sec.gov
Feb 18, 2021New notice$3,000,000$437,794$2,562,2064Jun 18, 2020sec.gov
Feb 18, 2021New notice$429,585$429,58518Aug 21, 2020sec.gov
Feb 17, 2021Amendment$10,000,050$5,055,793$4,944,25720Jul 15, 2019sec.gov
Feb 21, 2020Amendment$10,000,050$4,991,533$5,008,51719Jul 15, 2019sec.gov
Jul 30, 2019New notice$3,300,026$300,002$3,000,0243Jul 15, 2019sec.gov
Jul 30, 2019Amendment$4,999,906$4,999,90634Feb 25, 2019sec.gov
May 17, 2019Amendment$4,999,906$4,841,203$158,70333Feb 25, 2019sec.gov
May 6, 2019Amendment$4,999,906$4,791,275$208,63132Feb 25, 2019sec.gov
Apr 18, 2019Amendment$4,999,906$4,582,643$417,26329Feb 25, 2019sec.gov
Apr 5, 2019Amendment$4,999,906$2,797,905$2,202,00115Feb 25, 2019sec.gov
Mar 12, 2019New notice$4,999,906$494,123$4,505,7834Feb 25, 2019sec.gov
May 31, 2018Amendment$15,000,000$8,106,688$6,893,31252Mar 13, 2018sec.gov
Mar 23, 2018New notice$15,000,000$5,984,270$9,015,73038Mar 13, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
C. Eric HunterExecutive Officer, DirectorChief Executive Officer
Farrukh HameedDirector
Jay Phillip MorganDirector
J. Knox SingletonDirector
Douglas E. StonerDirector
John HandDirector

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Jun 29, 2026 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Pneuma Respiratory, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.